The PIIPPI trial, which stands for Povidone-Iodine Intranasal for Prophylaxis in front-line Physicians/health care workers and Inpatients, is the first in the country to study iodine as a prevention measure in people who are not COVID-positive.
The program is a collaboration of the UK CURE Alliance and Center for Clinical and Translational Science, who together moved the funding mechanism from concept to first award in 20 days.
Dr. Jagannadha ‘Jay’ Avasarala, neurologist with the Kentucky Neuroscience Institute (KNI), recently published a study with others from the University of Kentucky’s Department of Neurology based on the fact that symptoms of MS can overlap with another disease known as neuromyelitis optica spectrum disorder (NMOSD).
After retiring as a teacher and learning she was pre-diabetic at age 57, Mary Beth Castle lost 81 pounds and began a new career as a Community Health Educator in Johnson County, Kentucky.
A national leader in informatics research at the intersection of evidence-based policy and health care outcomes, Talbert has been at the forefront of building UK’s biomedical informatics capacity over the last 25 years.
Several research labs and core facilities will be testing the antibodies of recovered COVID-19 patients for a study to see how long they protect against reinfection.
The University of Kentucky CURE Alliance, in collaboration with the UK Center for Clinical and Translational Science, has issued RFAs for COVID-19 funding in three categories: health, materials and methods, and social sciences.
In recognition of the 50th Anniversary of Earth Day, the CCTS shares this video that would have opened the CCTS “Our Environment, Our Health” Spring Conference, originally scheduled for April 21.
The CCTS COVID-19 Research Registry and Specimen Bank will collect specimens from volunteers who have tested positive for or are suspected of having the virus. The biobank will work closely with the UK COVID-19 Unified Research Experts (CURE) Alliance team.
